What diseases is Semaglutide Injection mainly used to treat?

Semaglutide injection (Wegovy), a glucagon-like peptide-1 (GLP-1) receptor agonist, was initially used to treat type 2 diabetes. However, with the deepening of research, its indications have gradually expanded, and it has been particularly effective in weight management. The mechanism of Wegovy is mainly to improve blood sugar levels by imitating the effects of the GLP-1 hormone, enhancing insulin secretion and inhibiting glucagon secretion. In addition, GLP-1 receptor agonists can also reduce appetite and delay gastric emptying, thereby achieving weight loss. Therefore, Wegovy is widely used in the following major therapeutic areas:

1. Wegovy is approved for the treatment of obesity. It is suitable for adults and children 12 years and older who meet certain weight criteria, usually a body mass index (BMI) of more than 30, or a BMI of more than 27 and accompanied by at least one weight-related disease (such as hyperglycemia, hypertension, or hyperlipidemia). Wegovy helps patients lose weight and maintain weight loss with long-term use by reducing appetite and improving insulin sensitivity. The drug not only helps improve patients' weight management but also reduces the health risks associated with obesity.

2. Wegovy is also suitable for adult patients who are overweight and are at risk for cardiovascular disease. Use of Wegovy is intended to reduce the risk of major adverse cardiovascular events such as cardiovascular death, nonfatal myocardial infarction or nonfatal stroke in patients with cardiovascular disease who are obese or overweight. Wegovy can improve cardiovascular health while managing weight, thereby providing a more comprehensive treatment plan for patients at high risk of cardiovascular disease.

3. Wegovy is also suitable for overweight patients who have difficulty managing weight, especially when the overweight is accompanied by at least one weight-related comorbidity (such as diabetes, sleep apnea, high cholesterol, etc.). After using Wegovy, such patients can not only effectively lose weight, but also reduce the severity of weight-related symptoms and improve their overall health.

Keyword tags: semaglutide, GLP-1 receptor agonist, obesity treatment, weight management, overweight, cardiovascular disease, weight loss drugs, long-term weight loss, drug treatment

Reference materials:https://www.wegovy.com/